Literature DB >> 22553514

Single nucleotide polymorphisms of metabolic syndrome-related genes in primary open angle glaucoma.

Gang Zhou1, Bin Liu.   

Abstract

AIM: To analyze single nucleotide polymorphisms (SNP) of primary open angle glaucoma- and metabolic syndrome-related genes in primary open angle glaucoma (POAG), in order to elucidate the roles of metabolic syndrome as a risk factor in POAG progress.
METHODS: SNP genotypes and alleles of interleukin-6 (IL-6), IL-6 receptor (IL-6R), dopamine D(2) receptor (DRD(2)), beta-fibrinogen (FGB), peroxisome proliferator-activated receptor-γ2 (PPARG), transforming growth factor-β1 (TGF-β1), E-selectin (E-Sel), apolipoprotein A-5 (APOA5), C-reactive protein (CRP), ectonueleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), hepatic lipase (LIPC), adiponectin (ADIPOQ), paraoxonase 1 (PON1) and serine protease inhibitor E (SERPINE1) genes in POAG (n=37) and normal control (n=100) groups were measured with ABI Prism 7900HT Fluorescence Quantitative PCR and TaqMan SNP Genotyping fluorescence probe kit.
RESULTS: Genotypes and allele frequencies of IL-6R, IL-6, FGB, CRP, ENPP1, LIPC, ADIPOQ, PON1, and SERPINE1 in total POAG group were significantly different compared to the control group.
CONCLUSION: Metabolic syndrome as a risk factor for POAG may be associated with genotypes and allele frequencies of the related genes. The corresponding gene expression and function can affect POAG progress, including roles of SERPINE1 in extracellular matrix, ENPP1 in insulin inhibition, IL-6 in endogenous neuroprotection, IL-6, IL-6R and E-Sel in autoimmune response, LIPC and FGB in blood hyperviscosity syndrome, ADIPOQ in NOS/NO production, PON1 in vascular endothelial protection.

Entities:  

Keywords:  metabolic syndrome; primary open angle glaucoma; single nucleotide polymorphism

Year:  2010        PMID: 22553514      PMCID: PMC3340651          DOI: 10.3980/j.issn.2222-3959.2010.01.09

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  8 in total

1.  Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma.

Authors:  Yoko Inagaki; Yukihiko Mashima; Tomoyo Funayama; Yuichiro Ohtake; Nobuo Fuse; Noriko Yasuda; Takeo Fukuchi; Akira Murakami; Yoshihiro Hotta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

2.  Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma.

Authors:  Shiri Diskin; Janardan Kumar; Zhiyi Cao; Joel S Schuman; Tim Gilmartin; Steven R Head; Noorjahan Panjwani
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

3.  Systemic high-sensitivity C-reactive protein levels in normal-tension glaucoma and primary open-angle glaucoma.

Authors:  Wei-Wen Su; Wan-Jing Ho; Shih-Tsung Cheng; Shirley H L Chang; Shiu-Chen Wu
Journal:  J Glaucoma       Date:  2007-05       Impact factor: 2.503

4.  Primary open-angle glaucoma and serum lipids.

Authors:  Suzana Pavljasević; Mensura Asćerić
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

5.  Glaucoma is associated with peripheral vascular endothelial dysfunction.

Authors:  Wei-Wen Su; Shih-Tsung Cheng; Wan-Jing Ho; Pei-Kwei Tsay; Shiu-Chen Wu; Shirley H L Chang
Journal:  Ophthalmology       Date:  2008-02-20       Impact factor: 12.079

Review 6.  A review of the risk factors in primary open angle glaucoma.

Authors:  A E Omoti; O T Edema
Journal:  Niger J Clin Pract       Date:  2007-03       Impact factor: 0.968

7.  Risk factors for incident open-angle glaucoma: the Barbados Eye Studies.

Authors:  M Cristina Leske; Suh-Yuh Wu; Anselm Hennis; Robert Honkanen; Barbara Nemesure
Journal:  Ophthalmology       Date:  2007-07-16       Impact factor: 12.079

8.  [Protein C reactive and glaucoma].

Authors:  C Stefan; A Nenciu; Diana Melinte; Cristina Malcea; Irina Nae; Olga Afanasiuc
Journal:  Oftalmologia       Date:  2006
  8 in total
  6 in total

1.  Differentially expressed microRNAs in the aqueous humor of patients with exfoliation glaucoma or primary open-angle glaucoma.

Authors:  Michelle D Drewry; Pratap Challa; John G Kuchtey; Iris Navarro; Inas Helwa; Yanzhong Hu; Hongmei Mu; W Daniel Stamer; Rachel W Kuchtey; Yutao Liu
Journal:  Hum Mol Genet       Date:  2018-04-01       Impact factor: 6.150

2.  Higher serum lipids and oxidative stress in patients with normal tension glaucoma, but not pseudoexfoliative glaucoma.

Authors:  Necat Yilmaz; Deniz Turgut Coban; Asli Bayindir; Muhammet Kazım Erol; Hamit Yasar Ellidag; Ozlem Giray; Suha Sayrac; Seckin Ozgur Tekeli; Esin Eren
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

3.  Comprehensive bioinformatics analysis of trabecular meshwork gene expression data to unravel the molecular pathogenesis of primary open-angle glaucoma.

Authors:  Ilona Liesenborghs; Lars M T Eijssen; Martina Kutmon; Theo G M F Gorgels; Chris T Evelo; Henny J M Beckers; Carroll A B Webers; Johannes S A G Schouten
Journal:  Acta Ophthalmol       Date:  2019-06-14       Impact factor: 3.761

4.  The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Lely Retno Wulandari
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

5.  Paraoxonase 1 (PON1) promoter (-107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk.

Authors:  Birsen Can Demirdöğen; Canan Koçan Akçin; Ezgi Göksoy; Gizem Yakar; Tuğçe Öztepe; Sinem Demirkaya-Budak; Sinan Oflaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-10       Impact factor: 3.117

6.  Impact of aromatase absence on murine intraocular pressure and retinal ganglion cells.

Authors:  Xiaomin Chen; Yang Liu; Yi Zhang; Wendy R Kam; Louis R Pasquale; David A Sullivan
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.